Barbara Giesser, MD, neurologist, MS professional, Pacific Neuroscience Institute at Providence Saint John’s University hospital, Santa Monica, CA.
Gabriel Pardo, MD, director, Oklahoma Medical Research study Structure’s Several Sclerosis Center of Quality, Oklahoma City.
National Several Sclerosis Society: “Adherence.”
Several Sclerosis Trust (U.K.): “When Can You Securely Stop Taking Illness Customizing Drugs?”
Journal of Neurology, Neurosurgery, and Psychiatry: ” Ceasing disease-modifying treatment in MS after an extended relapse-free duration: a tendency score-matched research study.”
International Journal of MS Care: “Preventing Disease-Modifying Treatment in Nonrelapsing Several Sclerosis.
Patient-Centered Results Research Study Institute: “Can Some MS Clients Securely Stop Taking Medicines?”